Quest Diagnostics (DGX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Quest Diagnostics

    NYSE: DGX · Real-Time Price · USD
    183.46
    3.35 (1.86%)
    At close: Sep 05, 2025, 3:59 PM
    184.18
    0.39%
    Pre-market: Sep 08, 2025, 04:09 AM EDT

    Quest Diagnostics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 9.87B 9.25B 9.88B 10.79B
    Cost of Revenue
    		 6.63B 6.2B 6.45B 6.58B
    Gross Profit
    		 3.24B 3.07B 3.43B 4.21B
    Operating Income
    		 1.35B 1.26B 1.43B 2.38B
    Interest Income
    		 25M 11M 10M 1M
    Pretax Income
    		 1.19B 1.16B 1.28B 2.68B
    Net Income
    		 871M 854M 946M 2B
    Selling & General & Admin
    		 1.77B 1.61B 1.87B 1.73B
    Research & Development
    		 n/a n/a n/a n/a
    Other Expenses
    		 128M 192M 131M 101M
    Operating Expenses
    		 1.9B 1.81B 2B 1.83B
    Interest Expense
    		 226M 163M 148M 152M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 8.53B 7.99B 8.46B 8.41B
    Income Tax Expense
    		 273M 248M 264M 597M
    Shares Outstanding (Basic)
    		 111M 112M 116M 125M
    Shares Outstanding (Diluted)
    		 113M 113M 118M 128M
    EPS (Basic)
    		 7.80 7.59 8.12 15.90
    EPS (Diluted)
    		 7.69 7.52 7.98 15.53
    EBITDA
    		 1.89B 1.73B 1.82B 3.16B
    EBIT
    		 1.4B 1.29B 1.38B 2.75B
    Depreciation & Amortization
    		 493M 439M 437M 408M

    Add to Watchlist